Business Context and Reporting Period
This Form 8-K Current Report was filed by iSpecimen Inc. (ISPC) on December 30, 2024, covering events occurring on December 27, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC. It is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance data.
Material Changes
On December 27, 2024, the Board of Directors appointed Robert Bradley Lim, the Company's Chief Executive Officer, to the additional roles of Treasurer and Secretary. This appointment was made via written consent in accordance with the Company's Second Amended and Restated Bylaws.
Guidance, Outlook, and Management Commentary
Management confirmed that there were no changes to Mr. Lim's compensation or other terms of employment in connection with this appointment. The filing contains no forward-looking guidance, risk updates, or discussion of contingencies beyond the officer appointment.
Investor Verification Checklist
- Verify the effective date of the officer appointment (December 27, 2024).
- Confirm that no compensation adjustments were made to the CEO for the new roles.
- Review the Company's Second Amended and Restated Bylaws to understand the scope of the Treasurer and Secretary roles.
- Note that this filing does not contain updated financial statements or operational metrics.